Riyana Khalifa
Physician Assistant · Springfield, MANPI 1215613591
Payments from drug & device makers
Across 100 payments — averaging $22.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$453
- Novo Nordisk$372
- Amgen$306
- Boehringer Ingelheim$229
- Antares Pharma, Inc.$104
- AbbVie$94
- plus $730 from 14 others
What the payments were for
- Food & beverage$2,288100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 20 | $453 |
| Novo Nordisk | 17 | $372 |
| Amgen | 13 | $306 |
| Boehringer Ingelheim | 11 | $229 |
| Antares Pharma, Inc. | 4 | $104 |
| AbbVie | 5 | $94 |
| Tandem Diabetes Care, Inc. | 3 | $79 |
| Abbott | 1 | $77 |
| Sanofi-aventis U.S. LLC | 3 | $72 |
| Corcept Therapeutics | 3 | $72 |
| Exact Sciences | 3 | $67 |
| Chiesi USA, Inc. | 3 | $65 |
| Radius Health, Inc. | 3 | $64 |
| AstraZeneca | 2 | $49 |
| BETA Bionics, Inc. | 1 | $37 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Kyowa Kirin, Inc. | 2 | $35 |
| Ascendis Pharma Endocrinology Inc | 2 | $34 |
| Astellas Pharma US Inc | 1 | $22 |
| Insulet Corporation | 1 | $21 |
How this compares
$2,288 in reported general payments places this provider in the 90th percentile of 3,507 physician assistant providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 99 | $113,662 |
| MounjaroTirzepatide | 63 | $63,215 |
| TymlosAbaloparatide | 15 | $54,269 |
| OzempicSemaglutide | 37 | $42,159 |
| JardianceEmpagliflozin | 24 | $19,481 |
| EliquisApixaban | 14 | $13,203 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $12,717 |
| Humalog Kwikpen U-100Insulin Lispro | 29 | $7,318 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $6,376 |
| Admelog SolostarInsulin Lispro | 16 | $6,152 |
| Novolog FlexpenInsulin Aspart | 13 | $3,397 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 15 | $2,413 |
| Atorvastatin Calcium | 63 | $944 |
| Rosuvastatin Calcium | 17 | $801 |
| Levothyroxine Sodium | 67 | $750 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $453 | $176,877162 claims |
| Radius Health, Inc.Tymlos | $64 | $54,26915 claims |
| Novo NordiskOzempic | $372 | $42,15937 claims |
| Boehringer IngelheimJardiance | $229 | $19,48124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,507 physician assistant providers in Massachusetts.
Other physician assistant in Springfield
- Stacey PanasciSpringfield$113K
- Leslie SmithSpringfield$49K
- Kerri St GeorgeSpringfield$18K
- Cassandra AyreSpringfield$15K
- Marianne LangloisSpringfield$9K
- Christopher MasseyWilbraham$190K
- Lizabeth O ConnorEverett$182K
- Kimberly ComeauSwampscott$120K
- Jason RandWaltham$99K
- Karen ChunEast Boston$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.